View in EDS HTML Full Text PDF Full Text

4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer.

Saved in:
Bibliographic Details
Title: 4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer.
Authors: De Marchi T; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands; Postgraduate School of Molecular Medicine, Erasmus MC, University Medical Center, Rotterdam, The Netherlands. Electronic address: t.demarchi@erasmusmc.nl., Liu NQ; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. Electronic address: n.liu@ncmls.ru.nl., Stingl C; Department of Neurology, Erasmus MC, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. Electronic address: c.stingl@erasmusmc.nl., Timmermans MA; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. Electronic address: a.timmermans@erasmusmc.nl., Smid M; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. Electronic address: m.smid@erasmusmc.nl., Look MP; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. Electronic address: m.look@erasmusmc.nl., Tjoa M; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. Electronic address: milatjoa@hotmail.com., Braakman RB; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands; Postgraduate School of Molecular Medicine, Erasmus MC, University Medical Center, Rotterdam, The Netherlands. Electronic address: r.braakman@erasmusmc.nl., Opdam M; Division of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. Electronic address: m.opdam@nki.nl., Linn SC; Division of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. Electronic address: s.linn@nki.nl., Sweep FC; Department of Laboratory Medicine, Radboud University Medical Center, PO Box 9101, NL-6500 HB, Nijmegen, The Netherlands. Electronic address: f.sweep@labgk.umcn.nl., Span PN; Department of Radiation Oncology, Radboud University Medical Center, PO Box 9101, NL-6500 HB, Nijmegen, The Netherlands. Electronic address: P.Span@rther.umcn.nl., Kliffen M; Department of Pathology, Maasstad Hospital, Maasstadweg 21, 3079 DZ, Rotterdam, The Netherlands. Electronic address: KliffenM@maasstadziekenhuis.nl., Luider TM; Department of Neurology, Erasmus MC, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. Electronic address: t.luider@erasmusmc.nl., Foekens JA; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. Electronic address: j.foekens@erasmsumc.nl., Martens JW; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands; Cancer Genomics Center Netherlands, Amsterdam, The Netherlands. Electronic address: j.martens@erasmusmc.nl., Umar A; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. Electronic address: a.umar@erasmsumc.nl.
Source: Molecular oncology [Mol Oncol] 2016 Jan; Vol. 10 (1), pp. 24-39. Date of Electronic Publication: 2015 Aug 07.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 26285647
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22De+Marchi+T%22">De Marchi T</searchLink>; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands; Postgraduate School of Molecular Medicine, Erasmus MC, University Medical Center, Rotterdam, The Netherlands. Electronic address: t.demarchi@erasmusmc.nl.<br /><searchLink fieldCode="AU" term="%22Liu+NQ%22">Liu NQ</searchLink>; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. Electronic address: n.liu@ncmls.ru.nl.<br /><searchLink fieldCode="AU" term="%22Stingl+C%22">Stingl C</searchLink>; Department of Neurology, Erasmus MC, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. Electronic address: c.stingl@erasmusmc.nl.<br /><searchLink fieldCode="AU" term="%22Timmermans+MA%22">Timmermans MA</searchLink>; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. Electronic address: a.timmermans@erasmusmc.nl.<br /><searchLink fieldCode="AU" term="%22Smid+M%22">Smid M</searchLink>; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. Electronic address: m.smid@erasmusmc.nl.<br /><searchLink fieldCode="AU" term="%22Look+MP%22">Look MP</searchLink>; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. Electronic address: m.look@erasmusmc.nl.<br /><searchLink fieldCode="AU" term="%22Tjoa+M%22">Tjoa M</searchLink>; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. Electronic address: milatjoa@hotmail.com.<br /><searchLink fieldCode="AU" term="%22Braakman+RB%22">Braakman RB</searchLink>; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands; Postgraduate School of Molecular Medicine, Erasmus MC, University Medical Center, Rotterdam, The Netherlands. Electronic address: r.braakman@erasmusmc.nl.<br /><searchLink fieldCode="AU" term="%22Opdam+M%22">Opdam M</searchLink>; Division of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. Electronic address: m.opdam@nki.nl.<br /><searchLink fieldCode="AU" term="%22Linn+SC%22">Linn SC</searchLink>; Division of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. Electronic address: s.linn@nki.nl.<br /><searchLink fieldCode="AU" term="%22Sweep+FC%22">Sweep FC</searchLink>; Department of Laboratory Medicine, Radboud University Medical Center, PO Box 9101, NL-6500 HB, Nijmegen, The Netherlands. Electronic address: f.sweep@labgk.umcn.nl.<br /><searchLink fieldCode="AU" term="%22Span+PN%22">Span PN</searchLink>; Department of Radiation Oncology, Radboud University Medical Center, PO Box 9101, NL-6500 HB, Nijmegen, The Netherlands. Electronic address: P.Span@rther.umcn.nl.<br /><searchLink fieldCode="AU" term="%22Kliffen+M%22">Kliffen M</searchLink>; Department of Pathology, Maasstad Hospital, Maasstadweg 21, 3079 DZ, Rotterdam, The Netherlands. Electronic address: KliffenM@maasstadziekenhuis.nl.<br /><searchLink fieldCode="AU" term="%22Luider+TM%22">Luider TM</searchLink>; Department of Neurology, Erasmus MC, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. Electronic address: t.luider@erasmusmc.nl.<br /><searchLink fieldCode="AU" term="%22Foekens+JA%22">Foekens JA</searchLink>; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. Electronic address: j.foekens@erasmsumc.nl.<br /><searchLink fieldCode="AU" term="%22Martens+JW%22">Martens JW</searchLink>; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands; Cancer Genomics Center Netherlands, Amsterdam, The Netherlands. Electronic address: j.martens@erasmusmc.nl.<br /><searchLink fieldCode="AU" term="%22Umar+A%22">Umar A</searchLink>; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. Electronic address: a.umar@erasmsumc.nl.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101308230%22">Molecular oncology</searchLink> [Mol Oncol] 2016 Jan; Vol. 10 (1), pp. 24-39. <i>Date of Electronic Publication: </i>2015 Aug 07.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22John+Wiley+%26+Sons%2C+Inc%22">John Wiley & Sons, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101308230 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1878-0261 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215747891%22">15747891 </searchLink><i>NLM ISO Abbreviation: </i>Mol Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=26285647
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.molonc.2015.07.004
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 24
    Titles:
      – TitleFull: 4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: De Marchi T
      – PersonEntity:
          Name:
            NameFull: Liu NQ
      – PersonEntity:
          Name:
            NameFull: Stingl C
      – PersonEntity:
          Name:
            NameFull: Timmermans MA
      – PersonEntity:
          Name:
            NameFull: Smid M
      – PersonEntity:
          Name:
            NameFull: Look MP
      – PersonEntity:
          Name:
            NameFull: Tjoa M
      – PersonEntity:
          Name:
            NameFull: Braakman RB
      – PersonEntity:
          Name:
            NameFull: Opdam M
      – PersonEntity:
          Name:
            NameFull: Linn SC
      – PersonEntity:
          Name:
            NameFull: Sweep FC
      – PersonEntity:
          Name:
            NameFull: Span PN
      – PersonEntity:
          Name:
            NameFull: Kliffen M
      – PersonEntity:
          Name:
            NameFull: Luider TM
      – PersonEntity:
          Name:
            NameFull: Foekens JA
      – PersonEntity:
          Name:
            NameFull: Martens JW
      – PersonEntity:
          Name:
            NameFull: Umar A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2016 Jan
              Type: published
              Y: 2016
          Identifiers:
            – Type: issn-electronic
              Value: 1878-0261
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Molecular oncology
              Type: main
ResultId 1